
The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting the nerves in people vaccinated against respiratory syncytial virus (RSV).
Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.